AMAG Pharmaceuticals ROIC
What is the ROIC of AMAG Pharmaceuticals?
The ROIC of AMAG Pharmaceuticals, Inc. is -44.83%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with roic similar to AMAG Pharmaceuticals
- Rhino Resource Partners LP has ROIC of -45.00%
- Kaili Resources has ROIC of -45.00%
- Colossus Resources Corp has ROIC of -45.00%
- General Assembly has ROIC of -44.94%
- Minco Capital has ROIC of -44.85%
- Allogene Therapeutics Inc has ROIC of -44.83%
- AMAG Pharmaceuticals has ROIC of -44.83%
- Actual Experience plc has ROIC of -44.80%
- Scancell Plc has ROIC of -44.80%
- Emcore has ROIC of -44.79%
- Sensyne Health plc has ROIC of -44.72%
- Outset Medical has ROIC of -44.71%
- Extraction Oil & Gas has ROIC of -44.71%